Saliva testing

Last updated
Saliva nitric test strip (Berkeley Test) showing colored scale of nitric oxide status - See article and jump to Cardiovascular Disease, Nitric Oxide: a salivary biomarker for cardio-protection Saliva test for nitric oxide.jpg
Saliva nitric test strip (Berkeley Test) showing colored scale of nitric oxide status – See article and jump to Cardiovascular Disease, Nitric Oxide: a salivary biomarker for cardio-protection

Saliva testing or Salivaomics is a diagnostic technique that involves laboratory analysis of saliva to identify markers of endocrine, immunologic, inflammatory, infectious, and other types of conditions. Saliva is a useful biological fluid for assaying steroid hormones such as cortisol, genetic material like RNA, proteins such as enzymes and antibodies, and a variety of other substances, including natural metabolites, including saliva nitrite, a biomarker for nitric oxide status (see below for Cardiovascular Disease, Nitric Oxide: a salivary biomarker for cardio-protection). Saliva testing is used to screen for or diagnose numerous conditions and disease states, [1] including Cushing's disease, anovulation, HIV, cancer, parasites, hypogonadism, and allergies. Salivary testing has even been used by the U.S. government to assess circadian rhythm shifts in astronauts before flight and to evaluate hormonal profiles of soldiers undergoing military survival training. [2] [3]

Contents

Proponents of saliva testing cite its ease of collection, safety, non-invasiveness, affordability, accuracy, and capacity to circumvent venipuncture as the primary advantages when compared to blood testing and other types of diagnostic testing. Additionally, since multiple samples can be readily obtained, saliva testing is particularly useful for performing chronobiological assessments that span hours, days, or weeks. Collecting whole saliva by passive drool has a myriad of advantages. Passive drool collection facilitates large sample size collection. Consequently, this allows the sample to be tested for more than one biomarker. It also gives the researcher the ability to freeze the left over specimen to be used at a later time. Additionally, it lessens the possibility of contamination by eliminating extra collection devices and the need to induce saliva flow. [4]

The testing of salivation by the use of mercury was performed at least as early as 1685. [5] Testing the acidity of saliva occurred at least as early as 1808. [6] The clinical use of saliva testing occurred at least as early as 1836 in patients with bronchitis. [7] In 1959, scientists in the journal Cancer raised the possibility of using biochemical changes in acid phosphatases in saliva as an indicator of the presence of prostate cancer. [8]

More recent studies have focused on detection of steroid hormones and antibodies in the saliva. Recent applications emphasize the development of increasingly sophisticated techniques to detect additional proteins, genetic material, and markers of nutritional status. According to Wong, scientists are now viewing saliva as "a valuable biofluid…with the potential to extract more data than is possible currently with other diagnostic methods." [9]

Technique

Most saliva testing is performed using enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), high-resolution mass spectrometry (HRMS), or any number of newer technologies such as fiber-optic-based detection. All of these methods enable detection of specific molecules like cortisol, C-reactive protein (CRP), or secretory IgA. This type of testing typically involves collection of a small amount of saliva into a sterile tube followed by processing at a remote laboratory. Some methods of testing involve collecting saliva using an absorbent pad, applying a chemical solution, and monitoring for color change to indicate a positive or negative result. This method is commonly used as a point-of-care (POC) technique to screen for HIV. However, using absorbent pads and chemical solutions could very easily skew the results of immunoassays. Research by Dr. Douglas A. Granger and colleagues shows that outcomes for testosterone, DHEA, progesterone, and estradiol biomarkers are elevated when cotton-based collection materials are used as opposed to samples collected by other methods (i.e. passive drool). [10] Researchers are currently examining the expanding role of saliva testing as part of routine dental or medical office examinations where saliva collection is simple to perform. [9]

Physiologic basis

Salivary glands: 1.parotid, 2.submandibular, 3.sublingual. Illu quiz hn 02.jpg
Salivary glands: 1.parotid, 2.submandibular, 3.sublingual.

Humans have three major salivary glands: parotid, submandibular, and sublingual. These glands, along with additional minor salivary glands, secrete a rich mixture of biological chemicals, electrolytes, proteins, genetic material, polysaccharides, and other molecules. Most of these substances enter the salivary gland acinus and duct system from the surrounding capillaries via the intervening tissue fluid, although some substances are produced within the glands themselves. The level of each salivary component varies considerably depending on the health status of the individual and the presence of disease (oral or systemic). By measuring these components in the saliva, it is possible to screen for a variety of infections, allergies, hormonal disturbances, and neoplasms.

Clinical use

The following conditions are among those that can be detected through saliva testing (list not comprehensive): adrenal conditions (such as Cushing's disease/syndrome and Addison's disease), altered female hormone states (such as polycystic ovary syndrome [PCOS], menopause, anovulation, and hormonal alterations in cycling women), altered male hormone states (such as hypogonadism/andropause and hyperestrogenic states), metabolic disturbances (such as insulin resistance, diabetes, and metabolic syndrome), benign and metastatic neoplasms (such as breast cancer, pancreatic cancer, and oral cancer), infectious conditions (such as HIV, viral hepatitis, amoebiasis, and helicobacter pylori infection), and allergic conditions (such as food allergy).

Uses in behavioral research

Saliva testing also has specific uses in clinical and experimental psychological settings. Due to its ability to provide insight into human behavior, emotions, and development, it has been used to investigate psychological phenomenon such as anxiety, depression, PTSD, and other behavioral disorders. [11] Its primary purpose is to test cortisol and alpha amylase levels, which are indicative of stress levels. Salivary cortisol is a good stress index, with increased levels of cortisol correlating positively with increased levels of stress. Cortisol levels rise slowly over time and take a while to return to base level, indicating that cortisol is more associated with chronic stress levels. [12] Alpha amylase, on the other hand, spikes quickly when confronted with a stressor and returns to baseline soon after the stress has passed, making salivary amylase measurement a powerful tool for psychological research studying acute stress responses. [12] Samples are usually collected from participants by having them drool through a straw into a collection tube while experiencing a stimulus, with samples taken every few minutes to record the gradual change in stress hormone levels. Because the collection of saliva samples is non-invasive, it has the advantage of not introducing further stress on the participant that may otherwise distort results. [13]

In more specific studies looking at the link between cortisol levels and psychological phenomena, it has been found that chronic stressors such as life-threatening situations (example: diseases), depression, and social or economic hardship correlate with significantly higher cortisol levels. [13] In situations where a subject undergoes induced anxiety, high cortisol levels correspond with experiencing more physiological symptoms of nervousness, such as increased heart rate, sweating, and skin conductance. [14] Additionally, a negative correlation was discovered between baseline levels of cortisol and aggression. [15] Salivary cortisol levels can thus provide insight into a number of other psychological processes.

Alpha amylase levels in saliva provide a non-invasive way to examine sympathoadrenal medullary (SAM) activity, which can otherwise be measured with electrophysiological equipment or blood plasma readings. Salivary alpha amylase levels have been found to correlate with heightened autonomic nervous system activity levels, reacting in similar ways to the hormone norepinephrine. [16] Subsequent findings reveal a relationship between α-amylase and competition. Results showed that alpha amylase levels changed when reacting to competition, but not when anticipating it. Furthermore, by testing alpha amylase levels, scientists noticed a difference in reactivity behavior among individuals with previous experience in a similar situation. [17]

While saliva testing has the promise of becoming a valuable and more widely used tool in psychological research in the future, there are also some disadvantages to the method that must be kept in mind, including the cost of collecting and processing the samples and the reliability of the measure itself. There is a substantial amount of both within-person and between-person variability in cortisol levels that must be taken into account when drawing conclusions from studies. [18]

Many studies have been performed to further examine the variables that contribute to these within-person and between-person variances. Analyses of the variables that affect cortisol levels has yielded an extensive list of confounding variables.

Diurnal variation is a major factor for within-person variance because baseline cortisol levels have been known to differ based on the time of day. For normally developing individuals who follow a typical day–night schedule, cortisol production peaks during the last few hours of sleep. This peak is thought to aid in preparing the body for action and stimulate the appetite upon waking. [19] Diurnal variation is also affected by psychological conditions. For example, Early morning cortisol levels have been found to be elevated in shy children and late night levels elevated in depressed adolescents, particularly the between the hours of two and four PM. [19] This might be important for understanding emotions and depressive symptoms.

Other variables that affect within- and between-person variation are listed below. The list is not meant to be comprehensive and the impact of many of these variables could benefit from further research and discussion.

Evidence and current research

Cortisol and melatonin aberrations

Cortisol2.svg
Cortisol-3D-balls.png
Structure of the steroid hormone Cortisol

In 2008 the Endocrine Society published diagnostic guidelines for Cushing's syndrome, wherein they recommended midnight salivary cortisol testing on two consecutive days as one possible initial screening tool. [21] A 2009 review concluded that late-night salivary cortisol testing is a suitable alternative to serum cortisol testing for diagnosing Cushing's syndrome, reporting that both sensitivity and specificity exceeded ninety percent. [22] In 2010 Sakihara, et al., evaluated the usefulness and accuracy of salivary, plasma, and urinary cortisol levels and determined salivary cortisol to be the "method of choice" for Cushing's syndrome screening. [23] In 2008 Restituto, et al., found early morning salivary cortisol to be "as good as serum" as an Addison's disease screening technique. [24] In 2010 Bagcim et al., determined that saliva melatonin levels "reflect those in serum at any time of the day" and are a reliable alternative to serum melatonin to study the pineal physiology in newborns. [25] A 2008 review article described saliva melatonin testing as a "practical and reliable method for field, clinical, and research trials". [26]

Reproductive hormone irregularities

A 2009 study examined the use of saliva testing to measure estradiol, progesterone, dehydroepiandrosterone (DHEA), and testosterone levels in 2,722 individuals (male and female). The researchers confirmed the "good validity of [salivary] sex hormone measurements" and concluded that salivary testing was a good method for testing older adults due to the ease of in-home collection. [27]

However, other studies suggest that such tests do not represent either the amount of hormones in the blood, or their biological activity. Saliva testing is often used as part of bioidentical hormone replacement therapy, though it has been criticized for being expensive, unnecessary and meaningless. [28] [29] [30]

Female

In 2010 a study identified luteinizing hormone (LH) as an accurate salivary biomarker of ovulation in females. Researchers measured various hormones in the saliva throughout the menstrual cycle and found that salivary luteinizing hormone was reliably elevated during the ovulatory period and, for that reason, "salivary LH level is a reliable way to determine ovulation." [31] A 1983 study of various salivary steroid assays showed that daily salivary progesterone measurements "provides a valuable means of assessing ovarian function". [32] A 2001 study involved performing daily saliva collection from healthy subjects and plotting these over the entire menstrual cycle. The researchers determined that salivary estradiol and progesterone curves corresponded to the daily profiles normally observed in blood, although of lesser amplitude. [33] In 1999 researchers determined that ELISA-based saliva testing "can serve as a reliable [method] for estriol determination." [34] A 2007 article reported that the free testosterone measurement, including via saliva assay, represents "the most sensitive biochemical marker supporting the diagnosis of PCOS." [35] In 1990 Vuorento, et al., found that luteal phase defects, wherein progesterone levels decline prematurely within the menstrual cycle, were identified with high frequency using salivary progesterone testing among women with unexplained infertility. [36]

Male

In 2009 Shibayama, et al., examined the accuracy of salivary androgen measurement for diagnosing late-onset hypogonadism (age-related decline in androgens, often called "andropause"). Researchers determined that the accuracy of saliva testosterone and DHEA measurement exceeded 98.5% and that this method "has satisfactory applicability" in the diagnosis of late-onset hypogonadism. [37] A 2007 study reported a sensitivity and specificity of 100% for salivary testosterone in ruling out hypogonadism and concluded that salivary testosterone is a useful biomarker in the diagnosis of male androgen deficiency. [38] The use of salivary testosterone to screen for hypogonadism has been validated by other studies, including one involving 1454 individuals. Those researchers concluded that salivary testosterone is "an acceptable assay for screening for hypogonadism." [39]

Neoplastic conditions

Pancreatic cancer

A 2010 study by Zhang, et al., demonstrated that researchers were able to detect pancreatic cancer with high sensitivity and specificity (90.0% and 95.0%, respectively) by screening saliva for four specific mRNA biomarkers. [40] In a 2011 review article that examined pancreatic cancer biomarkers, Hamade and Shimosegawa concluded that clinical application of saliva biomarker testing is "beneficial for the screening and early detection of pancreatic cancer." [41]

Breast cancer

Cartoon representation of a complex between DNA and the protein p53 (described in Cho et al. Science 265 pp. 346, 1994) P53.png
Cartoon representation of a complex between DNA and the protein p53 (described in Cho et al. Science 265 pp. 346, 1994)

In 2008 Emekli-Alturfan, et al., compared saliva from breast cancer patients to that from healthy individuals and observed, notably, that breast cancer patients' samples contained dysplastic cells and reduced lipid peroxides. [42] A 2000 study compared the salivary levels of a breast cancer marker (HER2/neu) in healthy women, women with benign breast lesions, and women with breast cancer. Researchers found that the salivary (as well as serum) level of this marker was significantly higher in women with breast cancer than in healthy women and women with benign breast lesions; they went on to state that the marker may have potential as a tool for diagnosing breast cancer or detecting its recurrence. [43] A separate study corroborated these findings and further demonstrated that another breast cancer marker (CA15-3) was elevated while the tumor suppressor protein p53 was reduced in the saliva of women with breast cancer compared to healthy controls and women with benign breast lesions. [44]

Oral cancer

In 2010 Jou, et al., found that patients diagnosed with oral squamous cell carcinoma had elevated levels transferrin in saliva compared to healthy controls and, moreover, that salivary transferrin measurement using ELISA technique was "highly specific, sensitive, and accurate for the early detection of oral cancer." [45] A 2009 study reported that the levels of two biomarkers, Cyclin D1 (increased compared to controls) and Maspin (decreased compared to controls), had sensitivities and specificities of 100% for oral cancer detection when measured in saliva. [46] Saliva testing for specific mRNAs has been found to possess significant potential for oral cancer diagnosis. [47] In fact, there is evidence to suggest that saliva RNA diagnostics are slightly superior to serum RNA diagnostics, with the comparative receiver operating characteristic (ROC) value being 95% for saliva but only 88% for serum. [9] [48]

Glucose dysregulation

A 2009 study compared the saliva glucose levels of diabetic patients to those of non-diabetic controls. The authors reported that "salivary [glucose] concentration and excretion were much higher in diabetic patients than in control subjects." [49] In 2009 Rao, et al., investigated salivary biomarkers that could aid identification of type-2 diabetic individuals. Researchers found that sixty-five proteins, the majority of which are involved in regulating metabolism and immune response, were significantly altered in type-2 diabetics. [50] They further observed that the relative increase of these specific proteins was directly proportional to the severity of disease (i.e., they were somewhat elevated in pre-diabetics and significantly elevated in diabetics). [47] In 2010 Soell, et al., determined that one particular salivary biomarker (chromogranin A) was over-expressed in 100% of diabetic patients when compared to controls. [51] In 2010 Qvarnstrom, et al., conducted a cross-sectional analysis of 500 individuals and found that an increase in salivary lysozyme was "significantly associated with metabolic syndrome." [52]

Infectious conditions

Human immunodeficiency virus

Saliva test for HIV. Oraquick2.jpg
Saliva test for HIV.

The accuracy of saliva anti-HIV antibody testing has been demonstrated in numerous studies; two recent large-scale studies found both sensitivity and specificity to be 100%. The first of these was published in 2008 by Zelin, et al., and compared saliva antibody testing and serum antibody testing using ELISA technique in 820 individuals. [53] The second study, conducted by Pascoe, et al., compared saliva antibody testing to serum antibody testing using ELISA followed by confirmatory Western Blot analysis in 591 individuals. [54] The accuracy of saliva anti-HIV antibody testing has been confirmed by many additional studies, leading to approval of this method by the U.S. Food & Drug Administration in 2004. [55]

Viral hepatitis

Several studies have demonstrated diagnostic potential for salivary hepatitis testing. A 2011 study demonstrated that HBV surface antigen saliva testing using ELISA had a sensitivity and specificity of 93.6% and 92.6%, respectively. [56] Other studies found that saliva assay for anti-HAV antibodies (IgM and IgG) was an effective method to identify HAV-infected individuals. [57] [58] Hepatitis C has also been identified using salivary detection methods. Yaari, et al., reported in 2006 that saliva testing for anti-HCV antibodies yielded a sensitivity of 100% and a specificity that was "similar or better" when compared to serum testing. [59]

Parasitic infection

A 2010 study found that saliva-based detection of the parasite Entamoeba histolytica was superior to existing fecal detection methods for patients with E. histolytica-associated liver abscess. [60] In 2004 El Hamshary and Arafa found that salivary anti-E. histolytica IgA concentration had "predictive diagnostic value of intestinal amoebiasis…as well as in tissue amoebiasis." [61] A 1990 study that involved saliva testing for E. histolytica in 223 school children demonstrated a sensitivity and specificity of 85% and 98%, respectively. [62] In 2005 Stroehle, et al., determined that saliva detection of IgG antibodies against Toxoplasma gondii had a sensitivity and specificity of 98.5% and 100%, respectively. [63] A study published in 1990 demonstrated the diagnostic utility of saliva IgG testing in identifying neurocysticercosis secondary to Taenia solium . [64]

Helicobacter pylori infection

Electron micrograph of Helicobacter pylori possessing multiple flagella (negative staining) EMpylori.jpg
Electron micrograph of Helicobacter pylori possessing multiple flagella (negative staining)

In a 2005 study, researchers investigated the accuracy of Helicobacter pylori diagnosis in dyspeptic patients using salivary anti-H. pylori IgG levels. They determined that saliva testing for H. pylori antibodies "could be used reliably for screening dyspeptic patients in general practice." [65] That same year Tiwari, et al., examined the accuracy of testing saliva for H. pylori DNA and how well this correlated with presence of H. pylori detected via gastric biopsy. Based on their results, researchers concluded that saliva testing could serve as a reliable non-invasive detection method for H. pylori infection. [66]

Periodontitis

A 2009 study conducted by Koss, et al., studied salivary biomarkers of periodontal disease; their findings revealed that three substances (peroxidase, hydroxyproline and calcium) were significantly increased in the saliva of patients with periodontitis. [67] A 2010 study found that elevation of three saliva biomarkers (MMP-8, TIMP-1, and ICTP), particularly when analyzed using time-resolved immunofluorometric assay, was suggestive of periodontitis. [68]

Cardiovascular disease

CRP: a salivary biomarker for cardiovascular risk

Three-dimensional structure of C-reactive protein. PDB 1lj7 EBI.jpg
Three-dimensional structure of C-reactive protein.

In 2011 Punyadeera, et al., studied "the clinical utility of salivary C-reactive protein levels in assessing coronary events such as myocardial infarction in a primary health care setting." [69] Researchers found that saliva CRP levels in cardiac patients were significantly higher when compared to healthy controls. Furthermore, they found that saliva CRP correlated with serum CRP in cardiac patients and, thus, could be a useful tool for "large patient screening studies for risk assessment of coronary events." [69]

Nitric Oxide: a salivary biomarker for cardio-protection

Cardio-protective nitric oxide is generated in the body by a family of specific enzymes, nitric oxide synthase. An alternative pathway for the generation of nitric oxide is the nitrate-nitrite-nitric oxide pathway in which dietary inorganic nitrate is sequentially reduced to nitric oxide. [70] A necessary and obligatory step in the generation of nitric oxide by the non-nitric oxide synthase or alternative pathway involves the uptake of nitrate by the salivary gland, excretion in saliva, and subsequent reduction to nitrite by oral commensal bacteria in the mouth. [71]

Salivary nitrite is then further chemically reduced in blood and tissue to nitric oxide resulting in the lowering of blood pressure, inhibition of platelet aggregation, increasing cerebral blood flow and flow-mediated dilation, and decreasing oxygen cost during exercise. [72] [73] [74] A principal source of dietary inorganic nitrate, which is reduced to nitric oxide in the body, is from leafy green vegetables. [75] [76] The blood pressure lowering effects of leafy green vegetables, in particular, spinach and arugula, are abundant in anti-hypertensive diets such as the DASH diet. [77] Several papers have shown saliva nitrite levels correlate with blood nitrite levels which both serve as meaningful surrogates for blood pressure lowering effects.

Sobko et al. shows that Japanese traditional diets rich in leafy vegetables elevated both plasma and saliva nitrite levels with a corresponding decrease in blood pressure. [78]

Webb et al. in 2008 reinforced the obligatory role of saliva in humans to generate nitric oxide. Here, they showed ingestion of beet juice, a nitrate-rich food, by healthy volunteers markedly reduced blood pressure and by disrupting saliva, either by spitting or interrupting the bioconversion of dietary nitrate to nitrite in the mouth with anti-bacterial mouthwash, the chemical reduction of nitrate to nitrite to nitric oxide with an associated decease in blood pressure was abated. By blocking saliva from recirculating or preventing salivary nitrate from being chemically reduced to nitrite, it prevented a rise in plasma nitrite levels, and blocked a decrease in blood pressure as well as abolished nitric oxide-mediated inhibition of platelets aggregation confirming the cardio-protective effects were attributable to nitric oxide via the conversion of nitrate to nitrite in saliva. [79]

In a series of reports by Ahluwalia and colleagues, they showed in a cross over protocol of 14 volunteers who ingested inorganic nitrates, plasma and saliva nitrite level increased 3 hours post ingestion with a significant reduction of blood pressure. Nitrate extracted from blood by the salivary gland, accumulates in saliva, which is then reduced to nitric oxide to have a direct blood pressure lowering effect. Decreasing saliva nitrite in volunteers that already had elevated levels, a rise in systolic and diastolic blood pressure resulted. Furthermore, pre-hypertensives may be more sensitive to the blood pressure lowering effects of the dietary nitrate-nitrite-nitric oxide pathway. [80] [81] [82] Monitoring the bioconversion of plant-derived nitrate into salivary nitrite serves as a surrogate biomarker for total body nitric oxide status. [77]

Allergic states

A 2002 study explored the relationship between allergies and salivary immunoglobulin levels in eighty subjects. Researchers demonstrated an association between development of allergies and disturbances in saliva allergen-specific IgA levels (elevated compared to controls) and total secretory IgA (reduced compared to controls). [83] In 2011 Peeters, et al., identified characteristic aberrations in certain salivary metabolites that were associated with peanut-allergic individuals when compared to peanut-tolerant controls. [84] In 2003 Vojdani, et al., found that individuals exposed to various allergenic molds and mycotoxins showed "significantly higher levels of salivary IgA antibodies against one or more mold species." [85]

Chemical substances

In 2009 Pink, et al., reported that saliva testing had become so widespread that it had begun to replace urine testing as the standard for detecting illicit drugs and prescription medications. [86] Shin, et al., reported in 2008 that salivary detection of ethanol and three of its metabolites (methanol, ethylene glycol, and diethylene glycol) had "relatively high sensitivity and specificity" and that such testing facilitates rapid diagnosis of alcohol intoxication. [87] A 2002 study demonstrated that there was good agreement between saliva and breath ethanol analysis, and that chromatographic saliva ethanol assay is "specific…[and] shows good accuracy and precision." [88] In 2011 Vindenes, et al., investigated the viability of drug abuse monitoring using saliva, comparing this method to urine drug detection. Researchers found that several drug metabolites were detected more frequently in saliva than in urine; this was true for 6-monoacetylmorphine, amphetamine, methamphetamine, and N-desmethyldiazepam. [89] This same study showed that saliva testing could detect other drug metabolites, as well, although not as frequently as urine testing; this was the case for morphine, other benzodiazepines, cannabis, and cocaine. [86]

Selected criticism

Sensitivity and specificity

A three-dimensional structure of the "sex hormone-binding globulin (SHBG)". Sex Hormone-Binding Globulin.png
A three-dimensional structure of the "sex hormone-binding globulin (SHBG)".

One often cited criticism of using saliva as a diagnostic fluid is that biomarkers are present in amounts that are too low to be detected reliably. As Wong points out, however, this "is no longer a limitation" due to the development of increasingly sensitive detection techniques. [9] Advances in ELISA and mass spectrometry, in addition to the emergence of novel detection methods that take advantage of nanotechnology and other technologies, are enabling scientists and practitioners to achieve high analyte sensitivity.

Biomarker specificity is another consideration with saliva testing, much as it is with blood or urine testing. Many biomarkers are nonspecific (for example, CRP is a nonspecific inflammatory marker), and thus they can not be used alone to diagnose any particular disease. This issue is currently being addressed through identification of multiple biomarkers that are correlative of a disease; these can then be screened concomitantly to create a comprehensive panel of tests that significantly increases diagnostic specificity. Of note, certain types of saliva testing are considered by many to be more specific than blood testing; this is particularly true for steroid hormones. Since salivary hormone tests measure only those hormones that are not bound to sex hormone-binding globulin (SHBG) or albumin, they are regarded as reflecting only the bioactive ("free") fraction. [90] [91] With continued research into the field of salivary testing, accuracy parameters such as sensitivity and specificity will continue to improve.

Standardization

As with other diagnostic testing methods, one drawback of saliva testing is the variability that exists among diagnostic devices and laboratory analysis techniques, especially for measuring hormones. [92] Consequently, although a test result may be accurate and reliable within a particular assay method or laboratory, it may not be comparative to a test result obtained using a different method or laboratory. As the research community continues to validate and refine test methods and establish standard diagnostic ranges for various saliva biomarkers, this issue should be resolved. Recently, the U.S. National Institute of Health and Public Health Service each granted significant funding to further advancements in salivary testing, including the continued development of diagnostic standards. [9] [93]

See also

Related Research Articles

<span class="mw-page-title-main">Nitrate</span> Polyatomic ion (NO₃, charge –1) found in explosives and fertilisers

Nitrate is a polyatomic ion with the chemical formula NO−
3. Salts containing this ion are called nitrates. Nitrates are common components of fertilizers and explosives. Almost all inorganic nitrates are soluble in water. An example of an insoluble nitrate is bismuth oxynitrate.

<span class="mw-page-title-main">Sjögren syndrome</span> Autoimmune disease affecting the bodys moisture-producing glands

Sjögren syndrome or Sjögren's syndrome is a long-term autoimmune disease that affects the body's moisture-producing glands, and often seriously affects other organ systems, such as the lungs, kidneys, and nervous system.

<span class="mw-page-title-main">Cortisol</span> Human natural glucocorticoid hormone

Cortisol is a steroid hormone, in the glucocorticoid class of hormones and a stress hormone. When used as a medication, it is known as hydrocortisone.

Cushing's disease is one cause of Cushing's syndrome characterised by increased secretion of adrenocorticotropic hormone (ACTH) from the anterior pituitary. This is most often as a result of a pituitary adenoma or due to excess production of hypothalamus CRH that stimulates the synthesis of cortisol by the adrenal glands. Pituitary adenomas are responsible for 80% of endogenous Cushing's syndrome, when excluding Cushing's syndrome from exogenously administered corticosteroids. The equine version of this disease is Pituitary pars intermedia dysfunction.

A radioallergosorbent test (RAST) is a blood test using radioimmunoassay test to detect specific IgE antibodies in order to determine the substances a subject is allergic to. This is different from a skin allergy test, which determines allergy by the reaction of a person's skin to different substances.

An autoantibody is an antibody produced by the immune system that is directed against one or more of the individual's own proteins. Many autoimmune diseases are associated with such antibodies.

In medicine, a biomarker is a measurable indicator of the severity or presence of some disease state. It may be defined as a "cellular, biochemical or molecular alteration in cells, tissues or fluids that can be measured and evaluated to indicate normal biological processes, pathogenic processes, or pharmacological responses to a therapeutic intervention." More generally a biomarker is anything that can be used as an indicator of a particular disease state or some other physiological state of an organism. According to the WHO, the indicator may be chemical, physical, or biological in nature - and the measurement may be functional, physiological, biochemical, cellular, or molecular.

A nitrite test is a chemical test used to determine the presence of nitrite ion in solution.

<span class="mw-page-title-main">Antibody microarray</span> Form of protein microarray

An antibody microarray is a specific form of protein microarray. In this technology, a collection of captured antibodies are spotted and fixed on a solid surface such as glass, plastic, membrane, or silicon chip, and the interaction between the antibody and its target antigen is detected. Antibody microarrays are often used for detecting protein expression from various biofluids including serum, plasma and cell or tissue lysates. Antibody arrays may be used for both basic research and medical and diagnostic applications.

Pseudo-Cushing's syndrome or non-neoplastic hypercortisolism is a medical condition in which patients display the signs, symptoms, and abnormal cortisol levels seen in Cushing's syndrome. However, pseudo-Cushing's syndrome is not caused by a problem with the hypothalamic-pituitary-adrenal axis as Cushing's is; it is mainly an idiopathic condition, however a cushingoid appearance is sometimes linked to excessive alcohol consumption. Elevated levels of total cortisol can also be due to estrogen found in oral contraceptive pills that contain a mixture of estrogen and progesterone. Estrogen can cause an increase of cortisol-binding globulin and thereby cause the total cortisol level to be elevated.

The estrogen receptor test (ERT) is a laboratory test to determine whether cancer cells have estrogen receptors. This information can guide treatment of the cancer.

A circulating tumor cell (CTC) is a cell that has shed into the vasculature or lymphatics from a primary tumor and is carried around the body in the blood circulation. CTCs can extravasate and become seeds for the subsequent growth of additional tumors (metastases) in distant organs, a mechanism that is responsible for the vast majority of cancer-related deaths. The detection and analysis of CTCs can assist early patient prognoses and determine appropriate tailored treatments. Currently, there is one FDA-approved method for CTC detection, CellSearch, which is used to diagnose breast, colorectal and prostate cancer.

<span class="mw-page-title-main">Anti–citrullinated protein antibody</span> Autoantibodies

Anti-citrullinated protein antibodies (ACPAs) are autoantibodies that are directed against peptides and proteins that are citrullinated. They are present in the majority of patients with rheumatoid arthritis. Clinically, cyclic citrullinated peptides (CCP) are frequently used to detect these antibodies in patient serum or plasma.

Critical illness–related corticosteroid insufficiency is a form of adrenal insufficiency in critically ill patients who have blood corticosteroid levels which are inadequate for the severe stress response they experience. Combined with decreased glucocorticoid receptor sensitivity and tissue response to corticosteroids, this adrenal insufficiency constitutes a negative prognostic factor for intensive care patients.

Biological functions of nitric oxide are roles that nitric oxide plays within biology.

M30 Apoptosense® ELISA is an enzyme-linked immunosorbent assay developed for the detection of soluble caspase-cleaved keratin 18.

<span class="mw-page-title-main">C-terminal telopeptide</span> Chemical compound

The C-terminal telopeptide (CTX), also known as carboxy-terminal collagen crosslinks, is the C-terminal telopeptide of fibrillar collagens such as collagen type I and type II. It is used as a biomarker in the serum to measure the rate of bone turnover. It can be useful in assisting clinicians to determine a patient's nonsurgical treatment response as well as evaluate a patient's risk of developing complications during healing following surgical intervention. The test used to detect the CTX marker is called the Serum CrossLaps, and it is more specific to bone resorption than any other test currently available.

<span class="mw-page-title-main">Cancer biomarker</span> Substance or process that is indicative of the presence of cancer in the body

A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. Ideally, such biomarkers can be assayed in non-invasively collected biofluids like blood or serum.

<span class="mw-page-title-main">Kowarski syndrome</span> Medical condition

Kowarski syndrome describes cases of growth failure, despite the presence of normal or slightly high blood growth hormone by radioimmunoassay (RIA-GH) and low serum IGF1, and who exhibit a significant increase in growth rate following recombinant GH therapy.

The blood–saliva barrier (BSB) is a biological barrier that consists of the epithelial cell layers of the oral mucosa and salivary glands, and provides physiological separation between blood vessels and the saliva in the oral cavity. In Russian academic literature the barrier is usually called the hematosalivary or hematosalivarian barrier.

References

  1. ↑ Nonaka T, Wong DT (13 June 2022). "Saliva Diagnostics". Annual Review of Analytical Chemistry. 15 (1): 107–121. Bibcode:2022ARAC...15..107N. doi:10.1146/annurev-anchem-061020-123959. ISSN   1936-1327. PMC   9348814 . PMID   35696523. S2CID   249644061.
  2. ↑ Morgan CA, Wang S, Mason J, et al. (May 2000). "Hormone profiles in humans experiencing military survival training". Biol. Psychiatry. 47 (10): 891–901. doi:10.1016/s0006-3223(99)00307-8. PMID   10807962. S2CID   36241351.
  3. ↑ Whitson PA, Putcha L, Chen YM, Baker E (April 1995). "Melatonin and cortisol assessment of circadian shifts in astronauts before flight". J. Pineal Res. 18 (3): 141–7. doi:10.1111/j.1600-079x.1995.tb00152.x. PMID   7562371. S2CID   37522924. Archived from the original on 2021-11-23. Retrieved 2019-11-30.
  4. ↑ Granger Douglas A., Kivlighan Katie T., Fortunato Christine, Harmon Amanda G., Hibel Leah C., Schwartz Eve B., Whembolua Guy-Lucien (2007). "Integration of Salivary Biomarkers into Developmental and Behaviorally-oriented Research: Problems and Solutions for Collecting Specimens". Physiology & Behavior. 92 (4): 583–90. doi:10.1016/j.physbeh.2007.05.004. PMID   17572453. S2CID   22420479.
  5. ↑ Nicolas de Blégny (1685). Zodiacus Medico-Gallicus, sive miscellaneorum curiosorum, medico-physicorum sylloge. Vol. 5. Chouët. p. 149.
  6. ↑ Nicholson, William (1808). A Dictionary of Practical and Theoretical Chemistry: With Its Application to the Arts and Manufactures, and to the Explanation of the Phaenomena of Nature...: with Plates and Tables. Richard Phillips. p. 2 R 2.
  7. ↑ Johnson J, Johnson HJ, eds. (1836). "On the Chemical Condition of the Saliva, as an Indication of the difference Morbid Affections of the Stomach". The Medico-chirurgical Review and Journal of Practical Medicine. 24. Richard & George S. Wood: 231, 233.
  8. ↑ Loewy MA (14 March 2023). "Saliva: The next frontier in cancer detection". Knowable Magazine. doi: 10.1146/knowable-031323-1 . Archived from the original on 24 March 2023. Retrieved 20 March 2023.
  9. 1 2 3 4 5 Wong DT (March 2006). "Salivary diagnostics powered by nanotechnologies, proteomics and genomics". J Am Dent Assoc. 137 (3): 313–21. doi:10.14219/jada.archive.2006.0180. PMID   16570464. S2CID   4828883.
  10. ↑ Shirtcliff Elizabeth A., Granger Douglas A., Schwartz Eve, Curran Mary J. (2001). "Use of Salivary Biomarkers in Biobehavioral Research: Cotton-based Sample Collection Methods Can Interfere with Salivary Immunoassay Results". Psychoneuroendocrinology. 26 (2): 165–73. doi:10.1016/s0306-4530(00)00042-1. PMID   11087962. S2CID   28174088.
  11. ↑ "Salimetrics Salivary Research". Archived from the original on 2016-03-04. Retrieved 2012-12-11.
  12. 1 2 Takai N, Yamaguchi, M., Aragaki, T., Eto, K., Uchihashi, K., Nishikawa, Y. (2004). "Effect of psychological stress on the salivary cortisol and amylase levels in healthy young adults" (PDF). Archives of Oral Biology. 49 (12): 963–968. doi:10.1016/j.archoralbio.2004.06.007. PMID   15485637. Archived from the original (PDF) on 2014-05-15. Retrieved 2012-12-11.
  13. 1 2 Groschl M (November 2008). "Current status of salivary hormone analysis". Clinical Chemistry. 54 (11): 1759–1769. doi: 10.1373/clinchem.2008.108910 . PMID   18757583.
  14. ↑ Westenberg PM, Bokhorst CL, Miers AC, Sumter SR, Kallen VL, van Pelt J, Blöte AW (October 2009). "A prepared speech in front of a pre-recorded audience: subjective, physiological, and neuroendocrine responses to the Leiden Public Speaking Task". Biological Psychology. 82 (2): 116–124. doi:10.1016/j.biopsycho.2009.06.005. PMID   19576261. S2CID   26101772.
  15. ↑ Granger, Douglas A., L. A. Serbin, A. Schwartzman, P. Lehoux, and J. Cooperman. "Children's Salivary Cortisol, Internalizing Behaviour Problems, and Family Environment: Results from the Concordia Longitudinal Risk Project." Int. J. Behav. Dev. 22 (1998): 707-28. Web.
  16. ↑ Rohleder N, Nater, U. M., Wolf, J. M., Ehlert, U., Kirschbaum, C. (December 2004). "Psychosocial stress-induced activation of salivary alpha amylase: an indicator of sympathetic activity?". Annals of the New York Academy of Sciences. 1032 (1): 258–263. Bibcode:2004NYASA1032..258R. doi:10.1196/annals.1314.033. PMID   15677423. S2CID   18383779.
  17. ↑ Granger Douglas A., Kivlighan Kate T. (2006). "Salivary α-amylase Response to Competition: Relation to Gender, Previous Experience, and Attitudes". Psychoneuroendocrinology. 31 (6): 703–14. doi:10.1016/j.psyneuen.2006.01.007. PMID   16624493. S2CID   54321702.
  18. ↑ Nicolson NA (2008). L.J. Luecken and L.C. Gallo (ed.). Measurement of Cortisol. In: Handbook of Psychological Research Methods in Health Psychology (PDF). Sage Publications. pp. 37–74. Archived (PDF) from the original on 2011-04-09. Retrieved 2012-12-16.
  19. 1 2 Klimes-Dougan B., Hastings P., Granger D., Barbara U., Zahn-Waxler C. (2001). "Adrenocortical activity in at-risk and normally developing adolescents: Individual differences in salivary cortisol basal levels, diunal variation, and responses to social challenges". Development and Psychopathology. 13 (3): 695–719. doi:10.1017/s0954579401003157. PMID   11523855. S2CID   8862728.
  20. 1 2 3 4 5 6 7 8 9 10 11 12 13 Kudielka B, Hellhammer D, Wüst S (January 2009). "Why do we respond so differently? Reviewing determinants of human salivary cortisol responses to challenge". Psychoneuroendocrinology. 34 (1): 2–18. doi:10.1016/j.psyneuen.2008.10.004. PMID   19041187. S2CID   10150649.
  21. ↑ Nieman LK, Biller BM, Findling JW, et al. (May 2008). "The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline". J. Clin. Endocrinol. Metab. 93 (5): 1526–40. doi:10.1210/jc.2008-0125. PMC   2386281 . PMID   18334580.
  22. ↑ Raff H (October 2009). "Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency". J. Clin. Endocrinol. Metab. 94 (10): 3647–55. doi: 10.1210/jc.2009-1166 . PMID   19602555.
  23. ↑ Sakihara S, Kageyama K, Oki Y, et al. (2010). "Evaluation of plasma, salivary, and urinary cortisol levels for diagnosis of Cushing's syndrome". Endocr. J. 57 (4): 331–7. doi: 10.1507/endocrj.k09e-340 . PMID   20139634.
  24. ↑ Restituto P, Galofré JC, Gil MJ, et al. (June 2008). "Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders". Clin. Biochem. 41 (9): 688–92. doi:10.1016/j.clinbiochem.2008.01.015. PMID   18280810.
  25. ↑ Bagci S, Mueller A, Reinsberg J, Heep A, Bartmann P, Franz AR (July 2010). "Utility of salivary melatonin measurements in the assessment of the pineal physiology in newborn infants". Clin. Biochem. 43 (10–11): 868–72. doi:10.1016/j.clinbiochem.2010.04.059. PMID   20433823.
  26. ↑ Benloucif S, Burgess HJ, Klerman EB, et al. (February 2008). "Measuring melatonin in humans". J Clin Sleep Med. 4 (1): 66–9. doi:10.5664/jcsm.27083. PMC   2276833 . PMID   18350967.
  27. ↑ Gavrilova N, Lindau ST (November 2009). "Salivary sex hormone measurement in a national, population-based study of older adults". J Gerontol B Psychol Sci Soc Sci. 64 (Suppl 1): i94–105. doi:10.1093/geronb/gbn028. PMC   2763516 . PMID   19204073.
  28. ↑ Boothby LA, Doering PL (August 2008). "Bioidentical hormone therapy: a panacea that lacks supportive evidence". Curr. Opin. Obstet. Gynecol. 20 (4): 400–7. doi:10.1097/GCO.0b013e3283081ae9. PMID   18660693. S2CID   22449765.
  29. ↑ McBane SE (2008). "Easing vasomotor symptoms: Besides HRT, what works?". Journal of the American Academy of Physician Assistants. 21 (4): 26–31. doi:10.1097/01720610-200804000-00012. PMID   18468366. S2CID   36136887.
  30. ↑ Fugh-Berman A, Bythrow J (2007). "Bioidentical hormones for menopausal hormone therapy: variation on a theme". Journal of General Internal Medicine. 22 (7): 1030–4. doi:10.1007/s11606-007-0141-4. PMC   2219716 . PMID   17549577.
  31. ↑ Alagendran S, Archunan G, Prabhu SV, Orozco BE, Guzman RG (2010). "Biochemical evaluation in human saliva with special reference to ovulation detection". Indian J Dent Res. 21 (2): 165–8. doi: 10.4103/0970-9290.66625 . PMID   20657081.
  32. ↑ Riad-Fahmy D, Read GF, Walker RF (July 1983). "Salivary steroid assays for assessing variation in endocrine activity". J. Steroid Biochem. 19 (1A): 265–72. doi:10.1016/S0022-4731(83)80035-1. PMID   6887863.
  33. ↑ Gann PH, Giovanazzi S, Van Horn L, Branning A, Chatterton RT (January 2001). "Saliva as a medium for investigating intra- and interindividual differences in sex hormone levels in premenopausal women". Cancer Epidemiol. Biomarkers Prev. 10 (1): 59–64. PMID   11205490.
  34. ↑ Voss HF (January 1999). "Saliva as a fluid for measurement of estriol levels". Am. J. Obstet. Gynecol. 180 (1 Pt 3): S226–31. doi:10.1016/s0002-9378(99)70706-4. PMID   9914623.
  35. ↑ Sharquie KE, Al-Bayatti AA, Al-Ajeel AI, Al-Bahar AJ, Al-Nuaimy AA (July 2007). "Free testosterone, luteinizing hormone/follicle stimulating hormone ratio and pelvic sonography in relation to skin manifestations in patients with polycystic ovary syndrome". Saudi Med J. 28 (7): 1039–43. PMID   17603706.
  36. ↑ Vuorento T, Hovatta O, Kurunmäki H, Ratsula K, Huhtaniemi I (August 1990). "Measurements of salivary progesterone throughout the menstrual cycle in women suffering from unexplained infertility reveal high frequency of luteal phase defects". Fertil. Steril. 54 (2): 211–6. doi: 10.1016/s0015-0282(16)53691-7 . PMID   2116329.
  37. ↑ Shibayama Y, Higashi T, Shimada K, et al. (September 2009). "Simultaneous determination of salivary testosterone and dehydroepiandrosterone using LC-MS/MS: Method development and evaluation of applicability for diagnosis and medication for late-onset hypogonadism". J. Chromatogr. B. 877 (25): 2615–23. doi:10.1016/j.jchromb.2008.10.051. PMID   19010090.
  38. ↑ Arregger AL, Contreras LN, Tumilasci OR, Aquilano DR, Cardoso EM (November 2007). "Salivary testosterone: a reliable approach to the diagnosis of male hypogonadism". Clin. Endocrinol. 67 (5): 656–62. doi:10.1111/j.1365-2265.2007.02937.x. hdl: 11336/111684 . PMID   17953627. S2CID   1476891.
  39. ↑ Morley JE, Perry HM, Patrick P, Dollbaum CM, Kells JM (September 2006). "Validation of salivary testosterone as a screening test for male hypogonadism". Aging Male. 9 (3): 165–9. doi:10.1080/13685530600907993. PMID   17050116. S2CID   46288077.
  40. ↑ Zhang L, Farrell JJ, Zhou H, et al. (March 2010). "Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer". Gastroenterology. 138 (3): 949–57.e1–7. doi:10.1053/j.gastro.2009.11.010. PMC   2831159 . PMID   19931263.
  41. ↑ Hamada S, Shimosegawa T (2011). "Biomarkers of pancreatic cancer". Pancreatology. 11 Suppl 2 (2): 14–9. doi:10.1159/000323479. PMID   21464582. S2CID   2515447.
  42. ↑ Emekli-Alturfan E, Demir G, Kasikci E, et al. (February 2008). "Altered biochemical parameters in the saliva of patients with breast cancer". Tohoku J. Exp. Med. 214 (2): 89–96. doi: 10.1620/tjem.214.89 . PMID   18285665.
  43. ↑ Streckfus C, Bigler L, Dellinger T, Dai X, Kingman A, Thigpen JT (June 2000). "The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study". Clin. Cancer Res. 6 (6): 2363–70. PMID   10873088.
  44. ↑ Streckfus C, Bigler L, Tucci M, Thigpen JT (2000). "A preliminary study of CA15-3, c-erbB-2, epidermal growth factor receptor, cathepsin-D, and p53 in saliva among women with breast carcinoma". Cancer Invest. 18 (2): 101–9. doi:10.3109/07357900009038240. PMID   10705871. S2CID   25529330.
  45. ↑ Jou YJ, Lin CD, Lai CH, et al. (November 2010). "Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer". Anal. Chim. Acta. 681 (1–2): 41–8. Bibcode:2010AcAC..681...41J. doi:10.1016/j.aca.2010.09.030. PMID   21035601.
  46. ↑ Shpitzer T, Hamzany Y, Bahar G, et al. (October 2009). "Salivary analysis of oral cancer biomarkers". Br. J. Cancer. 101 (7): 1194–8. doi:10.1038/sj.bjc.6605290. PMC   2768098 . PMID   19789535.
  47. 1 2 Park NJ, Zhou H, Elashoff D, et al. (September 2009). "Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection". Clin. Cancer Res. 15 (17): 5473–7. doi:10.1158/1078-0432.CCR-09-0736. PMC   2752355 . PMID   19706812.
  48. ↑ Li Y, Elashoff D, Oh M, et al. (April 2006). "Serum circulating human mRNA profiling and its utility for oral cancer detection". J. Clin. Oncol. 24 (11): 1754–60. doi: 10.1200/JCO.2005.03.7598 . PMID   16505414.
  49. ↑ Jurysta C, Bulur N, Oguzhan B, et al. (2009). "Salivary glucose concentration and excretion in normal and diabetic subjects". J. Biomed. Biotechnol. 2009: 430426. doi: 10.1155/2009/430426 . PMC   2686806 . PMID   19503844.
  50. ↑ Matsubara K, Irie T, Uekama K (February 1997). "Spectroscopic characterization of the inclusion complex of a luteinizing hormone-releasing hormone agonist, buserelin acetate, with dimethyl-beta-cyclodextrin". Chem. Pharm. Bull. 45 (2): 378–83. doi: 10.1248/cpb.45.378 . PMID   9118452.
  51. ↑ Soell M, Feki A, Hannig M, Sano H, Pinget M, Selimovic D (February 2010). "Chromogranin A detection in saliva of type 2 diabetes patients". Bosn J Basic Med Sci. 10 (1): 2–8. doi:10.17305/bjbms.2010.2725. PMC   5596606 . PMID   20192923.
  52. ↑ Qvarnstrom M, Janket SJ, Jones JA, et al. (September 2010). "Association of salivary lysozyme and C-reactive protein with metabolic syndrome". J. Clin. Periodontol. 37 (9): 805–11. doi:10.1111/j.1600-051X.2010.01605.x. PMC   2923268 . PMID   20666873.
  53. ↑ Zelin J, Garrett N, Saunders J, et al. (October 2008). "An evaluation of the performance of OraQuick ADVANCE Rapid HIV-1/2 Test in a high-risk population attending genitourinary medicine clinics in East London, UK". Int J STD AIDS. 19 (10): 665–7. doi:10.1258/ijsa.2008.008132. PMID   18824617. S2CID   9367055.
  54. ↑ Pascoe SJ, Langhaug LF, Mudzori J, Burke E, Hayes R, Cowan FM (July 2009). "Field evaluation of diagnostic accuracy of an oral fluid rapid test for HIV, tested at point-of-service sites in rural Zimbabwe". AIDS Patient Care STDs. 23 (7): 571–6. doi:10.1089/apc.2008.0225. PMC   2856437 . PMID   19530953.
  55. ↑ U.S. Food & Drug Administration. Vaccines, Blood & Biologics. Complete List of Donor Screening Assays for Infectious Agents and HIV Diagnostic Assays. https://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/BloodDonorScreening/InfectiousDisease/ucm080466.htm Archived 2019-04-22 at the Wayback Machine
  56. ↑ Cruz HM, da Silva EF, Villela-Nogueira CA, et al. (2011). "Evaluation of saliva specimens as an alternative sampling method to detect hepatitis B surface antigen". J. Clin. Lab. Anal. 25 (2): 134–41. doi:10.1002/jcla.20447. PMC   6647618 . PMID   21438008.
  57. ↑ Tourinho RS, Amado LA, Villar LM, et al. (May 2011). "Importance of the cutoff ratio for detecting antibodies against hepatitis A virus in oral fluids by enzyme immunoassay". J. Virol. Methods. 173 (2): 169–74. doi:10.1016/j.jviromet.2011.01.014. PMID   21295610.
  58. ↑ Amado LA, Villar LM, de Paula VS, Gaspar AM (March 2008). "Comparison between serum and saliva for the detection of hepatitis A virus RNA". J. Virol. Methods. 148 (1–2): 74–80. doi:10.1016/j.jviromet.2007.10.020. PMID   18160140.
  59. ↑ Yaari A, Tovbin D, Zlotnick M, et al. (April 2006). "Detection of HCV salivary antibodies by a simple and rapid test". J. Virol. Methods. 133 (1): 1–5. doi:10.1016/j.jviromet.2005.09.009. PMID   16360219.
  60. ↑ Haque R, Kabir M, Noor Z, et al. (August 2010). "Diagnosis of amebic liver abscess and amebic colitis by detection of Entamoeba histolytica DNA in blood, urine, and saliva by a real-time PCR assay". J. Clin. Microbiol. 48 (8): 2798–801. doi:10.1128/JCM.00152-10. PMC   2916621 . PMID   20534800.
  61. ↑ El Hamshary EM, Arafa WA (December 2004). "Detection of IgA anti-Entamoeba histolytica in the patients' saliva". J Egypt Soc Parasitol. 34 (3 Suppl): 1095–104. PMID   15658064.
  62. ↑ del Muro R, Acosta E, Merino E, Glender W, Ortiz-Ortiz L (December 1990). "Diagnosis of intestinal amebiasis using salivary IgA antibody detection". J. Infect. Dis. 162 (6): 1360–4. doi:10.1093/infdis/162.6.1360. PMID   2230266.
  63. ↑ Stroehle A, Schmid K, Heinzer I, Naguleswaran A, Hemphill A (June 2005). "Performance of a Western immunoblot assay to detect specific anti-Toxoplasma gondii IgG antibodies in human saliva". J. Parasitol. 91 (3): 561–3. doi:10.1645/GE-423R. PMID   16108547. S2CID   36850191.
  64. ↑ Acosta E (1990). "Antibodies to the metacestode of Taenia solium in the saliva from patients with neurocysticercosis". J. Clin. Lab. Anal. 4 (2): 90–4. doi:10.1002/jcla.1860040204. PMID   2313474. S2CID   43590254.
  65. ↑ Sönmezoglu M, Baysal B, Ergen A, Barut SG (April 2005). "Detection and evaluation of salivary antibodies to Helicobacter pylori in dyspeptic patients". Int. J. Clin. Pract. 59 (4): 433–6. doi:10.1111/j.1368-5031.2005.00495.x. PMID   15853860. S2CID   24170124.
  66. ↑ Tiwari SK, Khan AA, Ahmed KS, et al. (May 2005). "Rapid diagnosis of Helicobacter pylori infection in dyspeptic patients using salivary secretion: a non-invasive approach". Singapore Med J. 46 (5): 224–8. PMID   15858691.
  67. ↑ Koss MA, Castro CE, Salúm KM, López ME (2009). "Changes in saliva protein composition in patients with periodontal disease". Acta Odontol Latinoam. 22 (2): 105–12. PMID   19839486.
  68. ↑ Gursoy UK, Könönen E, Pradhan-Palikhe P, et al. (June 2010). "Salivary MMP-8, TIMP-1, and ICTP as markers of advanced periodontitis". J. Clin. Periodontol. 37 (6): 487–93. doi: 10.1111/j.1600-051X.2010.01563.x . PMID   20507371.
  69. 1 2 Punyadeera C, Dimeski G, Kostner K, Beyerlein P, Cooper-White J (October 2011). "One-step homogeneous C-reactive protein assay for saliva" (PDF). J. Immunol. Methods. 373 (1–2): 19–25. doi:10.1016/j.jim.2011.07.013. PMID   21821037.
  70. ↑ Weitzberg E, Lundberg J (2013). "Novel aspects of dietary nitrate and human health". Annu Rev Nutr. 33: 129–59. doi:10.1146/annurev-nutr-071812-161159. PMID   23642194.
  71. ↑ Hezel M; Weitzberg E (2013) The oral microbiome and nitric oxide homoeostasis. Oral Dis. Jun 28. doi: 10.1111/odi.12157. [Epub ahead of print]
  72. ↑ Lundberg JO, Weitzberg E, Cole JA, Benjamin N. Nitrate, bacteria and human health (2004) Nat Rev Microbiol. 2:593-602. Erratum in: Nat Rev Microbiol. 2:681.
  73. ↑ Bailey SJ, Winyard P, Vanhatalo A, Blackwell JR, Dimenna FJ, Wilkerson DP, Tarr J, Benjamin N, Jones AM (2009). "Dietary nitrate supplementation reduces the O2 cost of low-intensity exercise and enhances tolerance to high-intensity exercise in humans". J Appl Physiol. 107 (4): 1144–55. doi:10.1152/japplphysiol.00722.2009. PMID   19661447. S2CID   32275350.
  74. ↑ Machha A, Schechter AN (2011). "Dietary nitrite and nitrate: a review of potential mechanisms of cardiovascular benefits". Eur J Nutr. 50 (5): 293–303. doi:10.1007/s00394-011-0192-5. PMC   3489477 . PMID   21626413.
  75. ↑ Shannon OM, Easton C, Shepherd AI, Siervo M, Bailey SJ, Clifford T (7 June 2021). "Dietary nitrate and population health: a narrative review of the translational potential of existing laboratory studies". BMC Sports Science, Medicine and Rehabilitation. 13 (1): 65. doi: 10.1186/s13102-021-00292-2 . PMC   8186051 . PMID   34099037. S2CID   235364237.
  76. ↑ Larsen FJ, Ekblom B, Sahlin K, Lundberg JO, Weitzberg E (2006). "Effects of dietary nitrate on blood pressure in healthy volunteers". N Engl J Med. 355 (26): 2792–3. doi: 10.1056/nejmc062800 . PMID   17192551.
  77. 1 2 "Turning DASH Strategy into Reality for Improved Cardio Wellness Outcomes: Part II". 2013-07-25. Archived from the original on 2015-02-17. Retrieved 2013-10-03.
  78. ↑ Sobko T, Marcus C, Govoni M, Kamiya S (2010). "Dietary nitrate in Japanese traditional foods lowers diastolic blood pressure in healthy volunteers". Nitric Oxide. 22 (2): 136–40. doi:10.1016/j.niox.2009.10.007. PMID   19887114.
  79. ↑ Webb AJ, Patel N, Loukogeorgakis S, Okorie M, Aboud Z, Misra S, Rashid R, Miall P, Deanfield J, Benjamin N, MacAllister R, Hobbs AJ, Ahluwalia A (2008). "Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite". Hypertension. 51 (3): 784–90. doi:10.1161/HYPERTENSIONAHA.107.103523. PMC   2839282 . PMID   18250365.
  80. ↑ Kapil V, Milsom AB, Okorie M, Maleki-Toyserkani S, Akram F, Rehman F, Arghandawi S, Pearl V, Benjamin N, Loukogeorgakis S, Macallister R, Hobbs AJ, Webb AJ, Ahluwalia A (2010) Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO" Hypertension 56(2):274-81. doi: 10.1161/HYPERTENSIONAHA.110.153536. Erratum in: Hypertension. 2010 Sep;56(3):e37-9.
  81. ↑ Ghosh SM, Kapil V, Fuentes-Calvo I, Bubb KJ, Pearl V, Milsom AB, Khambata R, Maleki-Toyserkani S, Yousuf M, Benjamin N, Webb AJ, Caulfield MJ, Hobbs AJ, Ahluwalia A (2013). "Enhanced vasodilator activity of nitrite in hypertension: critical role for erythrocytic xanthine oxidoreductase and translational potential". Hypertension. 61 (5): 1091–102. doi: 10.1161/HYPERTENSIONAHA.111.00933 . PMID   23589565.
  82. ↑ Kapil V, Haydar SM, Pearl V, Lundberg JO, Weitzberg E, Ahluwalia A (2013). "Physiological role for nitrate-reducing oral bacteria in blood pressure control". Free Radic Biol Med. 55: 93–100. doi:10.1016/j.freeradbiomed.2012.11.013. PMC   3605573 . PMID   23183324.
  83. ↑ Böttcher MF, Häggström P, Björkstén B, Jenmalm MC (September 2002). "Total and allergen-specific immunoglobulin A levels in saliva in relation to the development of allergy in infants up to 2 years of age". Clin. Exp. Allergy. 32 (9): 1293–8. doi:10.1046/j.1365-2222.2002.01470.x. PMID   12220466. S2CID   39007073.
  84. ↑ Peeters KA, Lamers RJ, Penninks AH, et al. (2011). "A search for biomarkers as diagnostic tools for food allergy: a pilot study in peanut-allergic patients". Int. Arch. Allergy Immunol. 155 (1): 23–30. doi:10.1159/000318654. PMID   21109745. S2CID   32383321.
  85. ↑ Vojdani A, Kashanian A, Vojdani E, Campbell AW (November 2003). "Saliva secretory IgA antibodies against molds and mycotoxins in patients exposed to toxigenic fungi". Immunopharmacol Immunotoxicol. 25 (4): 595–614. doi:10.1081/IPH-120026444. PMID   14686801. S2CID   34670364.
  86. 1 2 Pink R, Simek J, Vondrakova J, et al. (June 2009). "Saliva as a diagnostic medium". Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 153 (2): 103–10. doi: 10.5507/bp.2009.017 . PMID   19771133.
  87. ↑ Shin JM, Sachs G, Kraut JA (October 2008). "Simple diagnostic tests to detect toxic alcohol intoxications". Transl Res. 152 (4): 194–201. doi:10.1016/j.trsl.2008.07.002. PMC   2615242 . PMID   18940722.
  88. ↑ Gubała W, Zuba D (2002). "Saliva as an alternative specimen for alcohol determination in the human body". Pol J Pharmacol. 54 (2): 161–5. PMID   12139114.
  89. ↑ J Anal Toxicol. 2011 Jan;35(1):32-9. Oral fluid is a viable alternative for monitoring drug abuse: detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with Methadone or Buprenorphine. Vindenes V, Yttredal B, Oiestad EL, Waal H, Bernard JP, Mørland JG, Christophersen AS. Norwegian Institute of Public Health, Division of Forensic Toxicology and Drug Abuse, P.O. 4404, Nydalen, 0403 Oslo, Norway.
  90. ↑ Celec P, Ostaniková D, Skoknová M, Hodosy J, Putz Z, Kúdela M (2009). "Salivary sex hormones during the menstrual cycle". Endocr. J. 56 (3): 521–3. doi: 10.1507/endocrj.k09e-020 . PMID   19194049.
  91. ↑ Greenspan's Basic & Clinical Endocrinology, 8th Ed. Saliva Testing directly measures active steroid hormone levels. 2007.
  92. ↑ J Clin Endocrinol Metab. 2010 Dec;95(12):5141-3. Standardization of hormonal assays for the 21st century. Wartofsky L, Handelsman DJ.
  93. ↑ Miller CS, Foley JD, Bailey AL, et al. (February 2010). "Current developments in salivary diagnostics". Biomark Med. 4 (1): 171–89. doi:10.2217/bmm.09.68. PMC   2857781 . PMID   20387312.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.